Galanin and galanin receptor expression in neuroblastoma

Annals of the New York Academy of Sciences

Volumn 863, Issue , 1998, Pages 438-441

  Tuechler, C ^a   Hametner, R ^a   Jones, N ^a   Jones, R ^a   Iismaa, T P ^b   Sperl, W ^a   Kofler, B ^a  

^a St Johanns Spital   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GALANIN RECEPTOR;

CASE REPORT; CHROMOSOME 1; CHROMOSOME DELETION; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NORTHERN BLOTTING; ONCOGENE C MYB; PLOIDY; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032417252     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10718.x     Document Type: Conference Paper

References (5)

1. 1. KOGNER, P. 1995. Neuropeptides in neuroblastomas and ganglioneuromas. Prog. Brain Res. 104: 325-338.
2. 2. ROBBERECHT, P. et al. 1992. Structural requirements for the occupancy of pituitary adenylatecyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP (6-38) as a potent antagonist. Eur. J. Biochem. 207: 239-246.
3. 3. SETHI, T. et al. 1992. Growth of small cell lung cancer cells: Stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 52: 2737-2742.
4. 4. BAUER, F.E. et al. 1986. Localization and molecular forms of galanin in human adrenals: Elevated levels in pheochromocytomas. J. Clin. Endocrinol. Metab. 63: 1372-1378.
5. 5. BRODEUR, G.M. et al. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 11: 1466-1477.